Blog

Thor Halfdanarson: A good review for those encountering patients with t-MN

Thor Halfdanarson/mayoclinic.org

Sep 28, 2024, 16:29

Thor Halfdanarson: A good review for those encountering patients with t-MN

Thor Halfdanarson, Vice President at North American Neuroendocrine Tumor Society, shared the following insights about a paper by Sangeetha Venugopal and Amy E. DeZern, on X:

“Although there is little discussion of PRRT and therapy-related myeloid neoplasms, t-MN (MDS and AML) in here, this is a very good review for all who may encounter patients with t-MN or just want to know more about it.”

Authors: Sangeetha Venugopal, Amy E. DeZern.

Source: Thor Halfdanarson/X

Acute Myeloid Leukemia Amy E. DeZern cancer myelodysplastic syndromes North American Neuroendocrine Tumor Society OncoDaily Oncology PRRT Sangeetha Venugopal t-MN therapy-related myeloid neoplasms Thor Halfdanarson

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage